Dayra Therapeutics
PrivateLast Round
Series A
Nov 24, 2025
Total Funding Raised
$90M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Dayra Therapeutics is a biotechnology company that develops oral macrocyclic peptide therapeutics. The company combines its macrocycle discovery platform with computational design and modeling to create novel macrocyclic peptides that selectively target disease-relevant proteins, with the goal of expanding treatment options and improving patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dayra Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Dayra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 24, 2025 |
Dayra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 24, 2025
$70M round led by Versant Ventures.
Dayra Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dayra Therapeutics's valuation, stock price, and market status.